Mechanistic study of HES1/PI3K/Akt/mTOR signaling pathway in cisplatin-induced sensorineural hearing loss

Identifying the molecular mechanism behind cisplatin-induced hearing loss opens a potential therapeutic window to prevent ototoxicity (medication-related hearing damage) without compromising cancer treatment efficacy.